Chen L K, Mathieu-Mahul D, Sasportes M, Degos L, Bensussan A
Hum Immunol. 1986 Nov;17(3):214-23. doi: 10.1016/0198-8859(86)90273-9.
A T4+ proliferative, noncytotoxic cloned line acquires specific lytic function by treatment with recombinant interferon alpha or gamma. Simultaneous with the acquisition of this new cell function, a rearrangement of the T-cell receptor alpha gene occurs. These changes necessitate a revised concept of a T-cell clone regarding its T-cell receptor gene configuration and cell function.